Tokyo, Feb. 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060565) titled 'DPC study of endoscopic and surgical resection for rectal neuroendocrine tumors' on Feb. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Division of Endoscopy, Shizuoka Cancer Center
Condition:
Condition - Rectal neuroendocrine tumor
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the short-term outcomes of endoscopic and surgical resection for rectal neuroendocrine tumors using the DPC database.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with rectal neuroendocrine tumors registered in the DPC database who underwent endoscopic or surgical resection between January 2012 and December 2023.
Key exclusion criteria - - Patients who underwent simultaneous surgery for other diseases
- Patients with missing data
Target Size - 500
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 12 Month 15 Day
Date of IRB - 2026 Year 01 Month 21 Day
Anticipated trial start date - 2026 Year 02 Month 16 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069253
Disclaimer: Curated by HT Syndication.
